表紙
市場調查報告書

組織密封膠:醫療設備的開發平台評估

Tissue Sealants - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 404486
出版日期 內容資訊 英文 188 Pages
訂單完成後即時交付
價格
Back to Top
組織密封膠:醫療設備的開發平台評估 Tissue Sealants - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月01日內容資訊: 英文 188 Pages
簡介

本報告提供全球組織密封膠市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,加上產品特性比較分析 (臨床實驗的各進展階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 組織密封膠概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 組織密封膠:各企業現在臨床實驗中的開發中產品

  • 組織密封膠的企業:各臨床實驗階段的開發中產品
  • 組織密封膠:各臨床實驗階段的開發中產品

第5章 組織密封膠的企業·產品概要

  • Advanced Medical Solutions Group plc
    • 開發中產品及進行中的臨床實驗概要
  • Argon Medical Devices Inc.
  • Baxter International Inc
  • Biomedica Management Corp
  • Boston University
  • C. R. Bard Inc
  • Calmare Therapeutics Inc
  • Clemson University
  • Cohera Medical, Inc.
  • Covalent Medical, Inc. (Inactive)
  • DSM Biomedical B.V.
  • Emory University
  • Ethicon Endo-Surgery, Inc.
  • Gamma Therapeutics Inc
  • Gecko Biomedical
  • Grifols SA
  • Hemostasis, LLC
  • HyperBranch Medical Technology, Inc.
  • InVivo Therapeutics Corporation
  • John Hopkins University
  • Kollodis BioSciences, Inc.
  • Kuros Biosciences AG
  • LifeBond Ltd.
  • Medical Adhesive Revolution GmbH
  • Medisse BV
  • OptMed, Inc.
  • Pharming Group NV
  • Polyganics B.V.
  • Protein Polymer Technologies Inc (Inactive)
  • Sea Run Holdings Inc
  • Sealantis Ltd.
  • Shanghai Haohai Biological Technology Co., Ltd.
  • Surgical Sealants, Inc.
  • TEIJIN FIBERS製藥
  • Texas A&M University
  • The Medicines Company
  • University of Akron

第6章 組織密封膠市場:目前的趨勢 (全55件)

第7章 建議

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0834EPD

GlobalData's Medical Devices sector report, "Tissue Sealants - Medical Devices Pipeline Assessment, 2019" provides an overview of Tissue Sealants currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Sealants pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Sealants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Sealants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Tissue Sealants Overview 9

3 Products under Development 10

  • 3.1 Tissue Sealants - Pipeline Products by Stage of Development 10
  • 3.2 Tissue Sealants - Pipeline Products by Segment 11
  • 3.3 Tissue Sealants - Pipeline Products by Territory 12
  • 3.4 Tissue Sealants - Pipeline Products by Regulatory Path 13
  • 3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date 14
  • 3.6 Tissue Sealants - Ongoing Clinical Trials 15

4 Tissue Sealants - Pipeline Products under Development by Companies 16

  • 4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development 16
  • 4.2 Tissue Sealants - Pipeline Products by Stage of Development 18

5 Tissue Sealants Companies and Product Overview 20

  • 5.1 Adhesys Medical GmbH Company Overview 20
  • 5.2 Advanced Medical Solutions Group plc Company Overview 22
  • 5.3 Aleo BME Inc Company Overview 23
  • 5.4 Angiotech Pharmaceuticals Inc Company Overview 24
  • 5.5 Arch Therapeutics Inc Company Overview 25
  • 5.6 Arizona State University Company Overview 26
  • 5.7 Baxter International Inc Company Overview 27
  • 5.8 Biomedica Management Corp Company Overview 28
  • 5.9 Boston University Company Overview 29
  • 5.10 C. R. Bard Inc Company Overview 30
  • 5.11 Calmare Therapeutics Inc Company Overview 32
  • 5.12 Clemson University Company Overview 33
  • 5.13 Cohera Medical Inc Company Overview 34
  • 5.14 Covalent Medical, Inc. (Inactive) Company Overview 37
  • 5.15 DSM Biomedical BV Company Overview 38
  • 5.16 Elastagen Pty Ltd Company Overview 39
  • 5.17 Ethicon Endo-Surgery Inc Company Overview 40
  • 5.18 Gamma Therapeutics Inc Company Overview 41
  • 5.19 GATT Technologies BV Company Overview 42
  • 5.20 Grifols SA Company Overview 44
  • 5.21 Grifols USA LLC Company Overview 45
  • 5.22 Hemostasis LLC Company Overview 46
  • 5.23 HyperBranch Medical Technology Inc Company Overview 50
  • 5.24 Institute of Molecular Biology of Parana Company Overview 52
  • 5.25 InVivo Therapeutics Corp Company Overview 53
  • 5.26 Johns Hopkins University Company Overview 54
  • 5.27 Kollodis BioSciences Inc Company Overview 55
  • 5.28 Kuros Biosciences AG Company Overview 56
  • 5.29 Laser Tissue Welding, Inc. Company Overview 58
  • 5.30 LifeBond Ltd Company Overview 61
  • 5.31 Medisse BV (Inactive) Company Overview 65
  • 5.32 Pharming Group NV Company Overview 66
  • 5.33 Polyganics BV Company Overview 67
  • 5.34 Protein Polymer Technologies Inc (Inactive) Company Overview 73
  • 5.35 Purdue University Company Overview 74
  • 5.36 Samyang Biopharmaceuticals Corp Company Overview 75
  • 5.37 Sealantis Ltd. Company Overview 76
  • 5.38 Shanghai Haohai Biological Technology Co Ltd Company Overview 80
  • 5.39 Surgical Sealants, Inc. Company Overview 82
  • 5.40 Teijin Pharma Ltd Company Overview 83
  • 5.41 Texas A&M University Company Overview 84
  • 5.42 The Medicines Company Company Overview 86
  • 5.43 Tissium SA Company Overview 87
  • 5.44 University of Akron Company Overview 88

6 Tissue Sealants- Recent Developments 89

  • 6.1 Nov 19, 2019: ThermoGenesis Holdings announces improved third quarter 2019 financial results and provides corporate update 89
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 91
  • 6.3 Oct 31, 2019: Cesca Therapeutics to change name and ticker symbol to reflect new strategic focus 93
  • 6.4 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran 94
  • 6.5 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 95
  • 6.6 Oct 28, 2019: PolyNovo: Appointment non-executive director - Dr Robyn Elliott 96
  • 6.7 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 96
  • 6.8 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 98
  • 6.9 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 99
  • 6.10 Oct 08, 2019: Samyang Biopharm USA expands and strengthens its US operations and makes additions to executive team in key business areas 100

7 Appendix 184

  • 7.1 Methodology 184
  • 7.2 About GlobalData 187
  • 7.3 Contact Us 187
  • 7.4 Disclaimer 187

List of Tables

  • Table 1: Tissue Sealants - Pipeline Products by Stage of Development 11
  • Table 2: Tissue Sealants - Pipeline Products by Segment 12
  • Table 3: Tissue Sealants - Pipeline Products by Territory 13
  • Table 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
  • Table 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
  • Table 6: Tissue Sealants - Ongoing Clinical Trials 16
  • Table 7: Tissue Sealants Companies - Pipeline Products by Stage of Development 17
  • Table 8: Tissue Sealants - Pipeline Products by Stage of Development 19
  • Table 9: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 10: CUTIS - Product Status 21
  • Table 11: CUTIS - Product Description 21
  • Table 12: VIVO - Product Status 22
  • Table 13: VIVO - Product Description 22
  • Table 14: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 15: Next Generation Internal Fixation And Sealant Device - Product Status 23
  • Table 16: Next Generation Internal Fixation And Sealant Device - Product Description 23
  • Table 17: Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 18: Dural Sealant - Product Status 24
  • Table 19: Dural Sealant - Product Description 24
  • Table 20: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 21: Hemaseel HMN Fibrin Sealant - Product Status 25
  • Table 22: Hemaseel HMN Fibrin Sealant - Product Description 25
  • Table 23: Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 24: AC5 Surgery - Sealant - Product Status 26
  • Table 25: AC5 Surgery - Sealant - Product Description 26
  • Table 26: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 27: Laser-Activated Nanosealant - Product Status 27
  • Table 28: Laser-Activated Nanosealant - Product Description 27
  • Table 29: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 30: Tisseel Dura - Product Status 28
  • Table 31: Tisseel Dura - Product Description 28
  • Table 32: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 33: ClotBlock - Product Status 29
  • Table 34: ClotBlock - Product Description 29
  • Table 35: Boston University Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 36: Hydrogel-Based Aerosolized Sealant Dressing - Product Status 30
  • Table 37: Hydrogel-Based Aerosolized Sealant Dressing - Product Description 30
  • Table 38: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 39: Progel Dural Sealant - Product Status 31
  • Table 40: Progel Dural Sealant - Product Description 31
  • Table 41: Progel Emerald - Product Status 32
  • Table 42: Progel Emerald - Product Description 32
  • Table 43: Tridyne Peripheral - Product Status 32
  • Table 44: Tridyne Peripheral - Product Description 32
  • Table 45: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 46: Wound Sealant - Product Status 33
  • Table 47: Wound Sealant - Product Description 33
  • Table 48: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 49: Surgical Adhesive Hydrogel - Product Status 34
  • Table 50: Surgical Adhesive Hydrogel - Product Description 34
  • Table 51: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 52: Sylys Surgical Sealant - Product Status 35
  • Table 53: Sylys Surgical Sealant - Product Description 35
  • Table 54: Sylys Surgical Sealant - Drug Delivery - Product Status 36
  • Table 55: Sylys Surgical Sealant - Drug Delivery - Product Description 36
  • Table 56: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status 36
  • Table 57: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description 37
  • Table 58: Sylys Surgical Sealant - Orthopedic Procedures - Product Status 37
  • Table 59: Sylys Surgical Sealant - Orthopedic Procedures - Product Description 37
  • Table 60: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

List of Figures

  • Figure 1: Tissue Sealants - Pipeline Products by Stage of Development 11
  • Figure 2: Tissue Sealants - Pipeline Products by Segment 12
  • Figure 3: Tissue Sealants - Pipeline Products by Territory 13
  • Figure 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
  • Figure 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
  • Figure 6: Tissue Sealants - Ongoing Clinical Trials 16
Back to Top